Voya Investment Management LLC Avrobio, Inc. Transaction History

Voya Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $10,212 - $18,110	-13,617 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.29 - $4.04 $49,186 - $154,041	-38,129 Reduced 73.68%	13,617 $18,000
Q4 2021 Feb 14, 2022	BUY	$3.45 - $6.05 $125,500 - $220,080	36,377 Added 236.69%	51,746 $199,000
Q3 2021 Nov 15, 2021	BUY	$5.53 - $9.28 $519 - $872	94 Added 0.62%	15,369 $86,000
Q2 2021 Aug 16, 2021	BUY	$7.84 - $12.6 $2,328 - $3,742	297 Added 1.98%	15,275 $136,000
Q1 2021 May 17, 2021	BUY	$10.54 - $19.3 $19,077 - $34,933	1,810 Added 13.75%	14,978 $190,000
Q4 2020 Feb 16, 2021	BUY	$12.79 - $17.1 $29,634 - $39,620	2,317 Added 21.35%	13,168 $184,000
Q2 2020 Aug 14, 2020	SELL	$12.19 - $22.96 $10,178 - $19,171	-835 Reduced 7.15%	10,851 $189,000
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $17,004 - $45,903	1,687 Added 16.87%	11,686 $182,000
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $130,486 - $218,778	9,999 New	9,999 $201,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.